These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

67 related items for PubMed ID: 19775950

  • 1. Alkyl isothiocyanates suppress epidermal growth factor receptor kinase activity but augment tyrosine kinase activity.
    Nomura T, Uehara Y, Kawajiri H, Ryoyama K, Yamori T, Fuke Y.
    Cancer Epidemiol; 2009 Oct; 33(3-4):288-92. PubMed ID: 19775950
    [Abstract] [Full Text] [Related]

  • 2. Selective sensitivity to wasabi-derived 6-(methylsulfinyl)hexyl isothiocyanate of human breast cancer and melanoma cell lines studied in vitro.
    Nomura T, Shinoda S, Yamori T, Sawaki S, Nagata I, Ryoyama K, Fuke Y.
    Cancer Detect Prev; 2005 Oct; 29(2):155-60. PubMed ID: 15829375
    [Abstract] [Full Text] [Related]

  • 3. Preventive effect of oral administration of 6-(methylsulfinyl)hexyl isothiocyanate derived from wasabi (Wasabia japonica Matsum) against pulmonary metastasis of B16-BL6 mouse melanoma cells.
    Fuke Y, Shinoda S, Nagata I, Sawaki S, Murata M, Ryoyama K, Koizumi K, Saiki I, Nomura T.
    Cancer Detect Prev; 2006 Oct; 30(2):174-9. PubMed ID: 16647224
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of lipopolysaccharide-induced cyclooxygenase-2 transcription by 6-(methylsulfinyl) hexyl isothiocyanate, a chemopreventive compound from Wasabia japonica (Miq.) Matsumura, in mouse macrophages.
    Uto T, Fujii M, Hou DX.
    Biochem Pharmacol; 2005 Dec 05; 70(12):1772-84. PubMed ID: 16256955
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The antiproliferative effects of tyrosine kinase inhibitors tyrphostins on a human squamous cell carcinoma in vitro and in nude mice.
    Yoneda T, Lyall RM, Alsina MM, Persons PE, Spada AP, Levitzki A, Zilberstein A, Mundy GR.
    Cancer Res; 1991 Aug 15; 51(16):4430-5. PubMed ID: 1651159
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Induction of heparin-binding EGF-like growth factor and activation of EGF receptor in imatinib mesylate-treated squamous carcinoma cells.
    Johnson FM, Saigal B, Donato NJ.
    J Cell Physiol; 2005 Nov 15; 205(2):218-27. PubMed ID: 15887238
    [Abstract] [Full Text] [Related]

  • 10. Amlodipine, a Ca2+ channel blocker, suppresses phosphorylation of epidermal growth factor receptor in human epidermoid carcinoma A431 cells.
    Yoshida J, Ishibashi T, Yang M, Nishio M.
    Life Sci; 2010 Jan 16; 86(3-4):124-32. PubMed ID: 19951711
    [Abstract] [Full Text] [Related]

  • 11. Differential Pharmacological Activities of Oxygen Numbers on the Sulfoxide Moiety of Wasabi Compound 6-(Methylsulfinyl) Hexyl Isothiocyanate in Human Oral Cancer Cells.
    Lee MJ, Tseng WS, Lai JC, Shieh HR, Chi CW, Chen YJ.
    Molecules; 2018 Sep 21; 23(10):. PubMed ID: 30248933
    [Abstract] [Full Text] [Related]

  • 12. Alterations of the cytoskeletal organization in tumor cell lines by a cardiotonic drug, vesnarinone, through protein tyrosine phosphorylation.
    Yoshinaka Y, Katoh I, Kyushiki H, Sakamoto Y.
    Exp Cell Res; 1995 Jul 21; 219(1):21-8. PubMed ID: 7543053
    [Abstract] [Full Text] [Related]

  • 13. Cyclooxygenase-2 induction and prostaglandin E2 accumulation in squamous cell carcinoma as a consequence of epidermal growth factor receptor activation by imatinib mesylate.
    Johnson FM, Yang P, Newman RA, Donato NJ.
    J Exp Ther Oncol; 2004 Dec 21; 4(4):317-25. PubMed ID: 15844661
    [Abstract] [Full Text] [Related]

  • 14. Cytotoxic activity of epidermal growth factor-genistein against breast cancer cells.
    Uckun FM, Narla RK, Jun X, Zeren T, Venkatachalam T, Waddick KG, Rostostev A, Myers DE.
    Clin Cancer Res; 1998 Apr 21; 4(4):901-12. PubMed ID: 9563884
    [Abstract] [Full Text] [Related]

  • 15. AEE788: a dual family epidermal growth factor receptor/ErbB2 and vascular endothelial growth factor receptor tyrosine kinase inhibitor with antitumor and antiangiogenic activity.
    Traxler P, Allegrini PR, Brandt R, Brueggen J, Cozens R, Fabbro D, Grosios K, Lane HA, McSheehy P, Mestan J, Meyer T, Tang C, Wartmann M, Wood J, Caravatti G.
    Cancer Res; 2004 Jul 15; 64(14):4931-41. PubMed ID: 15256466
    [Abstract] [Full Text] [Related]

  • 16. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
    Rewcastle GW, Murray DK, Elliott WL, Fry DW, Howard CT, Nelson JM, Roberts BJ, Vincent PW, Showalter HD, Winters RT, Denny WA.
    J Med Chem; 1998 Feb 26; 41(5):742-51. PubMed ID: 9513602
    [Abstract] [Full Text] [Related]

  • 17. Loss of cytotoxic effect of epidermal growth factor (EGF) on EGF receptor overexpressing cells is associated with attenuation of EGF receptor tyrosine kinase activity.
    Gardner DP, Shimizu N.
    J Cell Physiol; 1994 Feb 26; 158(2):245-55. PubMed ID: 8106561
    [Abstract] [Full Text] [Related]

  • 18. In situ inhibition of tyrosine protein kinase by erbstatin.
    Imoto M, Umezawa K, Sawa T, Takeuchi T, Umezawa H.
    Biochem Int; 1987 Nov 26; 15(5):989-95. PubMed ID: 3501720
    [Abstract] [Full Text] [Related]

  • 19. A food-derived synergist of NGF signaling: identification of protein tyrosine phosphatase 1B as a key regulator of NGF receptor-initiated signal transduction.
    Shibata T, Nakahara H, Kita N, Matsubara Y, Han C, Morimitsu Y, Iwamoto N, Kumagai Y, Nishida M, Kurose H, Aoki N, Ojika M, Uchida K.
    J Neurochem; 2008 Dec 26; 107(5):1248-60. PubMed ID: 18796006
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid cells following psoralen/ultraviolet light treatment.
    Mermelstein FH, Abidi TF, Laskin JD.
    Mol Pharmacol; 1989 Dec 26; 36(6):848-55. PubMed ID: 2557535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.